Sherlock 3CG+™ TCS is indicated to be used in adult and adolescent (greater than 12 through 21) patients with CVADs, such as peripherally inserted central catheters (PICCs), central venous catheters (CVCs), implantable ports, and hemodialysis catheters; it is also indicated to be used in children, infants, and neonates with PICCs and centrally inserted central catheters (CICCs).
The Sherlock 3CG+™ TCS is designed to aid in CVAD tip positioning of catheters at least 2 Fr in size through real-time navigation and electrocardiogram (ECG) technology.
The Sherlock 3CG+™ TCS is indicated as an alternative method to chest X-ray and fluoroscopy for CVAD tip placement, eliminating harmful radiation. When compared to traditional PICC placement methods of blind placement and CXR, it has demonstrated proven time and observed cost savings, specifically reduction in time to release PICC patients for IV therapy, malposition rates and chest X-rays.2,3